Related Experiment Video
Updated: Feb 2, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Chinese Herbal Medicine for Osteosarcoma in the Mouse: A Systematic Review and Meta-Analysis
Jun-Li Chang1,2, Wen-Yi Wang1,2, Yi-Mian Li1,2
1Orthopedic Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Objective:
To summarize and critically assess the inhibitory effects of Chinese herbal medicine (CHM) on tumor volume and tumor weight for the treatment of osteosarcoma (OS) in mouse models.
Methods:
PubMed, Embase, Web of Science, China Knowledge Resource Integrated Database (CNKI), Wanfang Database, VIP Database, and Chinese BioMedical (CBM) were searched since their inception dates to March 10, 2016. Two reviewers independently selected the controlled studies estimating effects of CHM on mouse OS by administration in vivo. A pair-wise meta-analysis was performed. Twenty-five studies with adequate randomization were included in the systematic review.
Results:
CHM may significantly inhibit OS growth in mice, as assessed using the tumor weight [20 studies, n=443; 290 for CHM and 153 for the control: pooled mean difference (MD)=-2.90; 95% confidence interval (Cl): -3.50 to -2.31: P<0.01], tumor volume (16 studies, n=382; 257 for CHM and 125 for the control; pooled MD =-2.57; 95% Cl: -3.33 to -1.80; P<0.01) and tumor growth inhibition rate.
Conclusion:
CHM could significantly inhibit the growth of OS in mouse models, which might be supportive for the design of preclinical and clinical trials in future.
Insights
Chinese herbal medicine (CHM) shows significant potential in inhibiting osteosarcoma (OS) growth in mouse models. This meta-analysis supports CHM as a viable option for future preclinical and clinical trials in OS treatment.
Area of Science:
- Oncology
- Pharmacology
- Traditional Chinese Medicine
Background:
- Osteosarcoma (OS) is a primary bone malignancy with limited effective treatments.
- Chinese herbal medicine (CHM) has a long history of use in traditional medicine for various conditions.
- Investigating the efficacy of CHM in preclinical models is crucial for potential therapeutic development.
Purpose of the Study:
- To systematically review and critically evaluate the effects of CHM on tumor volume and weight in osteosarcoma mouse models.
- To provide a quantitative summary of CHM's inhibitory impact on OS tumor growth.
- To assess the potential of CHM as an adjuvant or alternative therapy for osteosarcoma.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (PubMed, Embase, Web of Science, CNKI, Wanfang, VIP, CBM) up to March 2016.
- Twenty-five randomized controlled studies involving CHM administration in vivo for osteosarcoma mouse models were included.
- A pair-wise meta-analysis was performed to pool the data on tumor weight and volume.
Main Results:
- CHM significantly inhibited osteosarcoma tumor weight (20 studies, n=443; pooled MD=-2.90, P<0.01) and tumor volume (16 studies, n=382; pooled MD=-2.57, P<0.01).
- The tumor growth inhibition rate was also significantly affected by CHM treatment.
- These findings indicate a consistent inhibitory effect of CHM on OS progression in mouse models.
Conclusions:
- CHM demonstrates a significant inhibitory effect on osteosarcoma growth in mouse models.
- The results suggest that CHM could be a supportive treatment strategy for osteosarcoma.
- Further preclinical and clinical trials are warranted to explore the therapeutic potential of CHM for osteosarcoma.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error

